anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The chemokine receptor CXCR4 is a co-receptor for T-tropic strains of HIV-1. A number of small molecule antagonists of CXCR4 are in development, but all are likely to lead to adverse effects due to the physiological function of CXCR4. To prevent these complications, allosteric agonists may be therapeutically useful as adjuvant therapy in combination with small molecule antagonists. A synthetic cDNA library coding for 160,000 different SDF-based peptides was screened for CXCR4 agonist activity in a yeast strain expressing functional receptor. Peptides that activated CXCR4 in an autocrine manner induced colony formation. Two peptides, designated RSVM and ASLW, were identified as novel agonists that are insensitive to the CXCR4 antagonist AMD3100. In chemotaxis assays using the acute lymphoblastic leukemia cell line CCRF-CEM, RSVM behaves as a partial agonist and ASLW as a superagonist. The superagonist activity of ASLW may be related to its inability to induce receptor internalization. In CCRF-CEM cells, the two peptides are also not inhibited by another CXCR4 antagonist, T140, or the neutralizing monoclonal antibodies 12G5 and 44717.111. These results suggest that alternative agonist binding sites are present on CXCR4 that could be screened to develop molecules for therapeutic use.
Pentobarbital Sodium should not be admixed with any other medication or solution. IV injection is restricted to conditions in which other routes are not feasible, either because the patient is unconscious (as in cerebral hemorrhage, eclampsia, or status epilepticus), or because the patient resists (as in delirium), or because prompt action is imperative. Slow IV injection is essential, and patients should be carefully observed during administration. This requires that blood pressure, respiration, and cardiac function be maintained, vital signs be recorded, and equipment for resuscitation and artificial ventilation be available. The rate of IV injection should not exceed 50 mg/min for Pentobarbital Sodium.

There is no average intravenous dose of Pentobarbital Sodium that can be relied on to produce similar effects in different patients. The possibility of overdose and respiratory depression is remote when the drug is injected slowly in fractional doses.

A commonly used initial dose for the 70 kg adult is 100 mg. Proportional reduction in dosage should be made for pediatric or debilitated patients. At least one minute is necessary to determine the full effect of intravenous pentobarbital. If necessary, additional small increments of the drug may be given up to a total of from 200 to 500 mg for normal adults.
Varenicline (VC) will be supplied in .5 mg tablets once per week during the active treatment period. During the first week of treatment (Week 3) participants will be instructed to take .5 mg once per day for days 1-3, and 0.5 mg twice per day for days 4-7. The investigators will maintain a target dose of 1mg twice per day for the remaining active treatment period. Additionally, participants will also receive Take Control counseling via video. NC+TAU will receive reinforcement for submitting any urine sample, regardless of test results.
Synthetic vaccine comprises a physiologically acceptable carrier on which is disposed a synthetic peptide residue (I) contg. a sequence of 6 amino acids corresp. to the sequence of such amino acids in a protein antigen or allergen where the greatest local average hydrophilicity is found. This hydrophilicity is determined by assigning relative values to the amino acids as follows: arginine 3.0; aspartic acid 3.0 + or -1; glutamic acid 3.0 + or -1; lysine 3.0; serine 0.3; asparagine 0.2; glutamine 0.2; glycine 0.0; proline-0.5 + or -1; threonine-0.4; alanine -0.5; histidine -0.5; cysteine -1.0; methionine -1.3; valine -1.5; isoleucine -1.8; leucine -1.8; tyrosine -2.3; phenylalanine -2.5; and tryptophan -3.4. Then the repetitive local average of hydrophilicity values at a number of points along the amino acid chain is determined. From the results the points of greatest local average hydrophilicity are determined. The vaccine when free from an amino acid sequence corresp. to the entire protein antigen or allergen evokes a protective immunological response by stimulation of antibody formation against an antigen or allergen when introduced into a host animal. The vaccines are formed without use of natural sera and so are free from contaminating serum proteins, viral residues, lipids, DNA etc.
Patients receive docetaxel IV over 15 minutes and irinotecan hydrochloride IV over 30 minutes on days 1 and 8. Treatment repeats every 3 weeks for 2 courses in the absence of disease progression or unacceptable toxicity. Beginning in week 8, patients receive docetaxel IV over 15 minutes and irinotecan hydrochloride IV over 30 minutes on days 1 (week 8) and 8 (week 9). Patients also undergo radiotherapy once daily, 5 days a week, in weeks 8-10. Treatment with chemoradiotherapy repeats every 3 weeks for 2 courses in the absence of disease progression or unacceptable toxicity.
Compositions and methods for the treatment of xerostomia are disclosed herein. Methods for making the compositions are also disclosed herein. The compositions are designed for individuals having the physiologic ability to salivate but who do not salivate in sufficient quantity to satisfy their personal comfort level of oral hydration. The compositions are typically in the form of a film or tablet, preferably in the form of a sticker tablet, most preferably in the form of a double layer sticker tablet, where one layer contains a bioadhesive material and the second layer contains the sialogogic agent and the one or more lipids. The compositions adhere to a buccal surface or mucosal surface in the oral cavity for at least 15 minutes, preferably for at least 30 minutes. The compositions contain a therapeutically effective amount of one or more sialogogic agents and one or more lipids for treating xerostomia and a pharmaceutically acceptable bioadhesive carrier. The compositions optionally contain a non-lipid lubricant, a flavoring agent, and/or a buffering agent. The methods for treatment of xerostomia require placing the composition on the oral mucosa of a patient's mouth, preferably on the palate or the cheek. The composition will adhere to the mucosal surface and dissolve over a period of time. The composition is generally effective at treating or ameliorating the effects of xerostomia for a time period ranging from at least 30 minutes up to 8 hours following administration to the buccal or oral mucosa.
Stress has been shown to modulate fear extinction. The present study is aimed at investigating whether stress (administered prior to exposure with the socially evaluated cold pressor test) augments exposure therapy outcome in patients with specific phobia (spider phobia). Furthermore, the effects of stress on the generalization of exposure-induced symptom reduction towards untreated fear stimuli (i.e. cockroaches) will be explored.

Participants are randomly assigned to the cold or warm water condition of the socially evaluated cold pressor test (SECPT; Schwabe et al., 2008). Thereafter, participants of both conditions receive 45 minutes of in-vivo exposure to spiders. The effects of stress on exposure-based anxiety reductions toward spiders (treated fear stimulus) and cockroaches (untreated fear stimulus to assess generalization of treatment outcome) are assessed on the behavioral, subjective and physiological level at pretreatment, posttreatment (24 hours after exposure) and follow-up (4 weeks after exposure).
PROBLEM TO BE SOLVED: To obtain a preventive for periodontal disease, capable of controlling the proliferation of mouth bacteria and effectively suppressing plaque formation, containing powder of an inorganic antimicrobial agent. SOLUTION: This preventive for periodontal disease comprises powder of an inorganic antimicrobial agent as an active ingredient containing an inorganic antimicrobial component such as silver or zinc. Powder obtained by supporting a solid, liquid or gaseous antimicrobial agent on a carrier such as aluminosilicate containing 0.7-4% of silver and 6.5-15% of zinc may be cited as the powder of the inorganic microbial agent. The preventive is optionally mixed with any of various carriers besides the powder of the inorganic antimicrobial agent and can be pharmaceutically manufactured into a cleaner, a disinfectant, a hypersensitivity inhibitor, a plaque stain, a dentifrice, a gingiva astringent, etc. The content of the powder of the inorganic antimicrobial agent is preferably 1-20% in various dosage forms.  The preventive for periodontal disease can control plaque formation for a long period of time in comparison with an organic medicine such as chlorhexidine as a therapeutic agent for inflammation.
OBJECTIVE: Aim: Determining the characteristics of urinary stone composition in inhabitants of an industrially advanced region afflicted with oxalate and urate urolithiasis.
PATIENTS AND METHODS: Materials and Methods: A comparative analysis of the morphology of 246 kidney stones from residents of one of heavily industrialized region of Ukraine, was conducted. Petrographic examination of the calculi was performed through microscopic analysis. The qualitative composition of the calculi was investigated using X-ray structural analysis of fragments and dust remnants of the stones, which were formed during the preparation of thin sections.
RESULTS: Results: A distinctive characteristic of all mineral components is their varying microblock structure and the presence of organic material inclusions. The inclusion of an organic component reduces the strength of the crystalline layers. Urolith resembles a brittle-hollow environment, which in certain cases allows for the selection of the most effective methods of their destruction (lithotripsy).
CONCLUSION: Conclusions: A common feature among all mineral components is their diverse microblock structure and the presence of organic inclusions, which diversify the strength characteristics of uroliths. The prior determination of these characteristics allows for the selection of the most ef f ective method for destructive treatment (lithotripsy). The combination of data on the ontogenesis of uroliths, their mineral composition, and the state of the electrolyte balance in the body of a patient with urolithiasis will allow choosing an individually effective method of metaphylaxis of the disease.
For the study 40 premolars from patients in the age group of 15-25 years, undergoing orthodontic treatment, in the Department of Orthodontics, MMCDSR, Mullana, Ambala, who had to get their premolars extracted as per their orthodontic treatment plan will be selected.

Only healthy premolars, with no caries, showing no signs and symptoms of pulpitis or periodontal diseases were selected. Medically compromised patients, or teeth with radiographic findings of external/internal resorption, bone loss, or calcifications in the pulp chamber will be excluded from the study. The selected premolars were then randomly divided into four equal groups namely: GROUP I - Direct pulp capping procedure performed using Biodentine. GROUP II - Direct pulp capping procedure performed using MTA. GROUP III - Direct pulp capping procedure performed using TheraCal LC. GROUP IV - Direct pulp capping procedure performed using Tristrontium aluminate.

The direct pulp capping procedure was carried out under rubber dam. The study protocol included class I cavity preparations on the premolars, followed by iatrogenic exposure of the pulp (0.5mm) using a sterile round bur, placement of the direct pulp capping agent according to the material of allotted to the study group. The teeth were permanently restored on the same visit, except for MTA group were the teeth were temporarily restored using Cavit G, and recalled after 1 day for permanent restoration. The patients were then enquired for any 94 SUMMARY 95 symptoms at 1 day and 7 days post operatively. The teeth were then, atraumatically extracted 3 months after the procedure. The extracted teeth were then put to CBCT as well as histopathological examination. Through CBCT evaluation, the completeness of the dentine bridge was evaluated. Histopathological examination was done to examine the pulpal response and the quality of the dentine bridge formed
Systemic oxidative stress stemming from increased free radical production and reduced antioxidant capacity are common characteristics of obese individuals. Using hydrogen peroxide (H2O2) to induce DNA damage in vitro, in peripheral blood mononuclear cells (PBMCs) from obese subjects and controls, the DNA protective ability of dihidroqercetin (DHQ) and biochaga (B) alone or in combination, were evaluated. The effects of DHQ and B were estimated under two experimental conditions: pre-treatment, where cells were pre-incubated with the substances prior to H2O2 exposure; and post-treatment when cells were first exposed to H2 H2O2, and further treated with the compounds. DNA damage was evaluated using the comet assay. The results of pre- and post-treatment showed a significant decrease in DNA damage produced by H2O2 in the obese group. This decrease was not significant in control group probably due to a small number of subjects in this pilot study. More prominent attenuation was noted in the pre-treatment with DHQ (250 μg/ml). Analysis of antioxidant properties revealed that DHQ's remarkable reducing power, 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging activity, and potent∙OH scavenging properties may contribute to strong attenuation of H2O2-induced DNA damage. Also, B showed strong reducing power, DPPH, and ∙OH scavenging ability, while reducing power and DPPH scavenger effects were increased in the presence of DHQ. Conclusively, DHQ and B may reduce H2O2-induced DNA damage in PBMCs from obese subjects when challenged in vitro, and could be valuable tools in future research against oxidative damage-related conditions.
OBJECTIVE: The pathogenic mechanisms of syphilis and the host defense mechanisms against syphilis remain poorly understood. Exploration of the susceptibility factors of syphilis may provide crucial clues for unraveling its underlying mechanisms.
METHODS: A two-sample Mendelian Randomization framework was utilized, and the inverse-variance weighted method was used as the main analysis. All data was sourced from Genome-wide association studies datasets from 2015 to 2022 in Europe, and all participants were of European descent. Only summary-level statistics were used. Sensitivity analyses were conducted to evaluate the heterogeneity and pleiotropy of the datasets.
RESULTS: Our study established 18 exposure factors (12 risk factors and 6 protective factors) for syphilis susceptibility. Twelve factors encompassing body mass index, waist circumference, darker natural skin, cooked vegetable intake, processed meat intake, diabetes mellitus, glucose regulation disorders, gout, autoimmune diseases, rheumatoid arthritis, diverticulitis, and longer menstrual cycles were found to increase susceptibility to syphilis. In contrast, 6 factors including easier skin tanning, blonde natural hair color, irritability, higher neuroticism scores, extended sleep duration, and delayed age at first sexual intercourse were connected to a reduced risk of syphilis infection (all P < 0.05).
CONCLUSIONS: This study identified 18 influencing factors of syphilis susceptibility. These findings offered novel insights for further probing into the underlying pathogenic mechanisms of syphilis and underscored the importance of multifaceted prevention strategies against syphilis.
Patients receive cabozantinib-s-malate PO daily and erlotinib hydrochloride PO QD on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Remote sensing of Solar-induced chlorophyll fluorescence (SIF) has been widely used in estimating Gross Primary Productivity (GPP) and detecting stress in terrestrial ecosystems. Water stress adversely impacts the growth, development, and productivity of a plant. Recently, the characterizing and understanding of the diurnal cycling of plant functioning and ecosystem processes has been explored using SIF. However, the diurnal response of SIF to different levels of water stress remains unclear. This study conducted field experiments on winter wheat by subjecting it to different levels of water stress including well-watered (CK) and, mild, moderate, and severe water stress (D1, D2, D3), and collected the spectral data using an automated SIF measurement system. The results observed the strong SIF-PAR (photosynthetically active radiation) correlations and that these relationships gradually decoupled with increasing water stress, which further decreased the accuracy of temporal upscaling of far-red SIF from an instantaneous to daily scale. To quantify the characteristics of diurnal far-red SIF, five indices including peak time, peak value, curve opening coefficient (leading coefficient of the parabola), and left/right slopes of the peak were proposed. The results demonstrated that diurnal far-red SIF was characterized by an earlier peak time, decreasing peak value, wider curve opening, and flattening right slope from the CK plot to the D3 plot. There were certain mechanisms linking the different indices, for example, between peak size and opening coefficient. Furthermore, the response of far-red SIF to water stress was most pronounced at noon. SIF/PAR exhibited a more significant response to varying water stress compared to far-red SIF, which mitigated the negative influence of PAR variations on diurnal SIF. These findings contribute to the monitoring of plant water dynamics at fine temporal scales.
The primary purpose of this study is to evaluate the effectiveness of trauma-focused group therapy for reducing HIV risk behavior and revictimization among adult women survivors of childhood sexual abuse (CSA). Research indicates that childhood sexual abuse is a major risk factor for becoming HIV-infected. Individuals with CSA may be less able to benefit from HIV/AIDS prevention intervention if they are continuing to be traumatized by their earlier CSA experiences that interfere with their learning safer patterns of interpersonal and personal functioning. This study will examine whether or not it is helpful to focus on survivors' memories of CSA in order to reduce HIV risk behavior, revictimization, and distress. It will also examine potential mediators of treatment effectiveness for CSA survivors. This randomized clinical intervention trial will compare trauma-focused group therapy against a present-focused group therapy comparison condition and a case-management only control condition. All three groups will be provided with case management. We will recruit a total of 192 adult women survivors of childhood sexual abuse through newspaper advertisements and through local community organizations (e.g., community health clinics, rape crisis centers). All 192 research participants will meet criteria for posttraumatic stress disorder (PTSD) for CSA as well as have engaged in HIV risk behavior and/or experienced sexual revictimization within the past 3 months. These research participants will be recruited for a randomized clinical intervention trial to evaluate the effectiveness of the trauma-focused and present-focused treatment conditions and to identify mediators of treatment effects. Women for the randomized clinical intervention trial will be recruited in eight cohorts of 24 subjects each for randomization to treatment condition (trauma-focused or present-focused or case management only). Intervention subjects will be assessed on behavioral and other psychosocial measures at baseline and at 3-, 6-, 9-, and 12-month follow-up assessments to evaluate the effectiveness of trauma-focused treatment against the present-focused treatment and the case management only control condition in reducing HIV risk behavior, sexual revictimization, and trauma symptoms, and improving interpersonal functioning. We will examine three mediators of treatment effectiveness, including: 1) trauma reactive and resilient beliefs about self and the world; 2) differentiation and integration of self; and 3) interpersonal relations.
PURPOSE:To provide a compound labeled with radioactive iodine useful for the quantitative determination of proteins, etc., economically, without deteriorating the biochemical properties of the original compound, by adjusting the ratio of the amount of the oxidizing agent added in the preparation of the labeled compound to the amount of the stabilizing agent for the radioactive iodine to a specific level. CONSTITUTION:A compound labeled with radioactive iodine useful for the quantitative determination of proteins, etc. by radio-isotope method, is prepared by using an oxidizing agent such as chloramine-T, hydrogen peroxide, etc. to be added to the reaction system in an amount of >=0.5 equivalent based on the amount of the reducing agent such as sodium thiosulfate, etc. to be added to the radioactive iodine as a stabilizer. The proteins such as mouse EGF (epidermal growth factor), etc. and the constituent amino acids can be labeled with the radioactive iodine having high specific radioactivity in high labeling yield without deteriorating the biochemical properties of the proteins, etc.
Chronic hepatitis B virus (HBV) infection is due to the failure of host immune system to resolve the viral infection. Accordingly, restoration or reconstitution of a functional antiviral immune response to HBV is essential to achieve durable control of HBV replication leading to a functional cure of chronic hepatitis B (CHB). Noninfectious subviral particles (SVPs), comprised of HBV surface antigen (HBsAg), are the predominant viral products secreted by HBV-infected hepatocytes. The high levels of SVPs in the circulation induce immune tolerance and contribute to the establishment of chronic HBV infection. The current standard-of-care medications for CHB efficiently suppress HBV replication but fail to reduce the levels of HBsAg in majority of treated patients. Further understanding the mechanisms underlying SVP morphogenesis, secretion and regulation by viral and host cellular factors are critical for the discovery of therapeutics that can inhibit SVP production and/or induce the degradation of HBV envelope proteins. We describe herein a protocol for intracellular SVP detection by a native agarose gel electrophoresis-based particle gel assy. The method is suitable for quantitative detection of intracellular HBV SVPs and can be applied in dissecting the molecular mechanism of SVP morphogenesis and the discovery of antiviral agents targeting SVP formation in hepatocytes.
DBT group has 55 patients, maybe will be divided them into 6 groups. Every group has 8-10 patients. Every group receive 12 times DBT group therapy and 1 times a week for 120 minutes each time.